Mina Pharm Pharmaceuticals

مادة اعلانية

Latest Update: 23 July 2025 15:14 Abu Dhabi Time.

Market Status: Closed

MIPH

Mina Pharm Pharmaceuticals

232.00

EGP

-0.110

-0.05%

Open

232.11

Prev Close

232.11

PX_VOLUME

799

MARKET CAP (M)

DAY RANGE

226.00 - 232.00

52 WEEKS

145.00 - 268.50

Stock Statistics

Yearly Change

22.02%

Listed Shares (Million)

12.29

Earnings Multiple

16.35

Average 30-day trading volume

3,249.87

Price-to-book ratio

0.66

Earnings Per Share

14.20

Previous Dividend Distribution

1.57

Dividend Yield

0.71%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Revenue		2,084.40	1,512.97	1,083.09	984.33	842.48	1,006.20
Gross Profit		866.14	578.25	270.84	221.41	165.53	348.77
Operating Income		329.81	292.63	70.93	0.65	-127.17	117.79
Profit Margin		7.03	6.89	-10.01	1.90	-15.89	0.88

	Period Ending:	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Revenue		5,664.78	3,892.05	3,620.54	3,005.35	2,361.01
Gross Profit		1,936.63	1,251.57	1,496.37	1,185.34	904.48
Operating Income		694.03	252.06	895.43	683.13	487.28
Profit Margin		2.84	0.57	17.43	15.80	13.16

Balance Sheet

	Period Ending:	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Assets		12,003.30	11,828.14	11,269.76	11,106.48	8,703.56	8,007.77
Total Liabilities		7,594.26	7,381.74	7,185.25	6,916.52	5,186.25	4,617.82
Total Equity		4,409.03	4,446.40	4,084.51	4,189.96	3,517.32	3,389.95

	Period Ending:	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Assets		12,003.30	8,703.56	6,805.89	4,105.62	3,483.02
Total Liabilities		7,594.26	5,186.25	3,765.30	2,162.61	1,889.77
Total Equity		4,409.03	3,517.32	3,040.59	1,943.01	1,593.26

Cash Flows Statements - Coming Soon

* In Million of Egypt Pound

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.

MIPH

Mina Pharm Pharmaceuticals